
Shares of Innovent Biologics 1801.HK jump 8.6% to HK$86.3, set for its biggest one-day pct gain since September 1
Innovent has struck a new deal with Eli Lilly LLY.N to develop immunology and oncology drugs, under which the U.S. drugmaker will pay $350 mln upfront and as much as $8.5 bln more if milestones are met
YTD, stock up 11.3%, Hang Seng Biotech Index .HSBIO up 9.5%